The technical experts are reviewing Moderna Inc.’s Covid-19 vaccine for possible emergency use listing by WHO. The TAG (Technical Advisory Group) will review the COVID-19 vaccine candidate by the US drugmaker and the results are expected in four days.
Amid this positive news French drug make Sanofi SA has come forward to manufacture and package required doses of Moderna’s COVID-19 vaccine in the U.S. The company has signed the contract which runs through April 2022 that states that Sanofi SA would fill vials and finish packaging of Moderna’s COVID-19 vaccines for the U.S. supply.
The post WHO to Review Moderna Vaccine for emergency listing against COVID-19 appeared first on Insights Care.
This post first appeared on Turmeric – An Eminent Element Of Natural Cures, please read the originial post: here
